Warner Bros. Discovery, Inc.
ESTROGEN RECEPTOR ANTAGONIST

Last updated:

Abstract:

Provided is an indole compound. In particular, disclosed are a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof and a use of the same as an estrogen receptor antagonist in preparing a drug for treating estrogen receptor-positive breast cancer. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

17 Dec 2019

Issue date:

3 Feb 2022